Medicare Part D provides prescription drug coverage through Medicare approved plans
offered by private insurance companies and HMOs. In this paper, we study the role of current …

While health care policies are frequently signed into law well before they are implemented,
such lags are ignored in most empirical work. This paper demonstrates the importance of …

The development over the past 25 years of methods for the estimation of discrete choice
dynamic programming (DCDP) models opened up new frontiers for empirical research in a …

We evaluate the impact of the Medicare HMO program and prescription drug coverage on
elderly mortality using data from 1993 to 2000. We specify a model of plan entry and benefit …

We seek to investigate whether managed health care can affect mortality, and if so, through
which mechanisms. We estimate the impact of Medicare+ Choice (M+ C), Medicare's …

Medicare's Part D offers heavily subsidized new drug coverage to 22.5 million seniors to
date, of whom 16.5 million are in stand-alone drug plans (Department of Health and Human …

With states facing tightening Medicaid budgets, the high cost of financing long-term care for
the elderly through Medicaid has prompted proposals to make private long-term care …

Medicare's Part D offered heavily subsidized new drug coverage to 22.5 million seniors in
2006 (and over 25 million in 2008), of whom roughly 17 million were in standalone drug …

One of the most controversial issues in health policy is whether private, non-statutory health
insurance schemes succeed in providing comprehensive coverage. Overcoming adverse …

The expansion of Medicare benefits to include coverage for prescription drug (Part D) is the
largest since the program's inception. The benefit is delivered through private insurers …